Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

29
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
29
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

24
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
24
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

437
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
437
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

281
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
281
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The burden of steroid use in systemic lupus erythematosus.

Rheumatology (Oxford, England)·2026
Same author

Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus.

EULAR rheumatology open·2026
Same author

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same author

Psychometric Evaluation and Discriminative Validity of the Short-Form Brief Pain Inventory Across Nociceptive, Neuropathic, and Nociplastic Pain Mechanisms.

The journal of pain·2026
Same author

Belimumab induces early and sustained resolution of lupus thrombocytopenia.

Lupus science & medicine·2026
Same author

The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same journal

MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.

Journal of autoimmunity·2026
Same journal

Neonatal total parenteral nutrition and the risk of childhood autoimmune diseases: A nationwide population-based study of 2.3 million children.

Journal of autoimmunity·2026
Same journal

Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.

Journal of autoimmunity·2026
Same journal

Intermittent fasting ameliorates Sjögren's syndrome-related dry eye through a preponderant bile acid-Akkermansia homeostasis establishment.

Journal of autoimmunity·2026
Same journal

High-intensity immunosuppression versus modern standard care in poor-prognosis diffuse cutaneous systemic sclerosis: A propensity-matched study.

Journal of autoimmunity·2026
Same journal

Efficacy, safety, and tolerability of treatments for interstitial lung disease associated with rtoid arthritis: A systematic review and network meta-analysis.

Journal of autoimmunity·2026
See all related articles

Related Experiment Video

Updated: Sep 7, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K

Advances in SLE classification criteria.

Martin Aringer1, Karen Costenbader2, Thomas Dörner3

  • 1Division of Rheumatology, Department of Medicine III, and University Center for Autoimmune and Rheumatic Entities (UCARE). University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany.

Journal of Autoimmunity
|June 20, 2022
PubMed
Summary
This summary is machine-generated.

The American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus (SLE) have evolved over 40 years. Recent EULAR/ACR criteria are now the standard for clinical trials and patient management.

Keywords:
Classification criteriaClinical trialsSensitivitySpecificitySystemic lupus erythematosus

More Related Videos

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

213
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

195

Related Experiment Videos

Last Updated: Sep 7, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

213
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

195

Area of Science:

  • Rheumatology
  • Immunology
  • Clinical Criteria Development

Background:

  • The 1982 American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus (SLE) marked a significant starting point.
  • Subsequent updates and alternative criteria, including the Systemic Lupus International Collaborating Clinics (SLICC) criteria in 2012, aimed to refine SLE classification.
  • The 2019 European League Against Rheumatism (EULAR)/ACR classification criteria represent the latest advancement in defining SLE.

Purpose of the Study:

  • To provide a comprehensive review of the evolution of SLE classification criteria over the past four decades.
  • To highlight key decisions, their rationale, and the impact on SLE definition and management.
  • To discuss the success story and ongoing development of SLE classification systems.

Main Methods:

  • Historical review of major SLE classification criteria development.
  • Analysis of the rationale behind significant revisions and new criteria.
  • Examination of the external validation and adoption of recent criteria, particularly the EULAR/ACR criteria.

Main Results:

  • The ACR 1982 criteria have undergone significant evolution, leading to multiple iterations and alternative frameworks.
  • The 2019 EULAR/ACR criteria have demonstrated robust external validation across numerous studies.
  • These recent criteria have become the established gold standard for SLE inclusion in clinical trials.

Conclusions:

  • The journey of SLE classification criteria reflects a continuous effort to improve diagnostic accuracy and clinical trial rigor.
  • The EULAR/ACR criteria have achieved widespread acceptance and validation, significantly impacting SLE research and clinical practice.
  • Understanding the historical context and evolution of these criteria is crucial for the future definition and management of SLE.